Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PEYTAVIN, Gilles")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 130

  • Page / 6
Export

Selection :

  • and

Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant womenMANDELBROT, Laurent; PEYTAVIN, Gilles; FIRTION, Ghislaine et al.American journal of obstetrics and gynecology. 2001, Vol 184, Num 2, pp 153-158, issn 0002-9378Article

Severe insomnia related to high concentrations of raltegravirEIDEN, Céline; PEYRIERE, Hélène; PEYTAVIN, Gilles et al.AIDS (London). 2011, Vol 25, Num 5, pp 725-727, issn 0269-9370, 3 p.Article

Les antagonistes du récepteur CCR5: une nouvelle classe d'antirétroviraux = CCR5 Antagonists: a New Class of AntiretroviralsPEYTAVIN, Gilles; CALVEZ, Vincent; KATLAMA, Christine et al.Thérapie (Paris). 2009, Vol 64, Num 1, pp 9-16, issn 0040-5957, 8 p.Article

Passage transplacentaire des antiretroviraux (ARV) = Placental transfer of antiretroviral drugsPEYTAVIN, Gilles.Reproduction humaine et hormones. 2000, Vol 13, Num 7-8, pp 756-761, issn 0994-3919Conference Paper

Suspected Interaction Between Sorafenib and HAART in an HIV-1 Infected Patient: A Case ReportOZENNE, Violaine; GERVAIS, Anne; PEYTAVIN, Gilles et al.Hepato-gastroenterology. 2011, Vol 58, Num 105, pp 161-162, issn 0172-6390, 2 p.Article

Once-daily administration of antiretrovirals: Pharmacokinetics of emerging therapiesTABURET, Anne-Marie; PACI-BONAVENTURE, Sabine; PEYTAVIN, Gilles et al.Clinical pharmacokinetics. 2003, Vol 42, Num 14, pp 1179-1191, issn 0312-5963, 13 p.Article

Placental transfer of enfuvirtide in the ex vivo human placenta perfusion modelCECCALDI, Pierre-Francois; FERREIRA, Claudia; GAVARD, Laurent et al.American journal of obstetrics and gynecology. 2008, Vol 198, Num 4, pp 433-434, issn 0002-9378, 2 p.Article

Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion modelFORESTIER, Francois; DE RENTY, Patrick; PEYTAVIN, Gilles et al.American journal of obstetrics and gynecology. 2001, Vol 185, Num 1, pp 178-181, issn 0002-9378Article

Pharmacokinetic and pharmacodynamic interaction between grapefruit juice and halofantrineCHARBIT, Beny; BECQUEMONT, Laurent; LEPERE, Bénédicte et al.Clinical pharmacology and therapeutics. 2002, Vol 72, Num 5, pp 514-523, issn 0009-9236, 10 p.Article

Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DFDELAUGERRE, Constance; ROUDIERE, Laurent; PEYTAVIN, Gilles et al.Journal of clinical virology. 2005, Vol 32, Num 3, pp 241-244, issn 1386-6532, 4 p.Article

High indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitorsBOSSI, Philippe; PEYTAVIN, Gilles; LAMOTTE, Claire et al.AIDS (London). 2003, Vol 17, Num 7, pp 1108-1110, issn 0269-9370, 3 p.Article

Severe cardiac toxicity due to halofantrine: Importance of underlying heart diseaseBOUCHAUD, Olivier; BRUNEEL, Fabrice; SCHIEMANN, Ricarda et al.Journal of travel medicine. 2002, Vol 9, Num 4, pp 214-215, issn 1195-1982Article

Unexpected atazanavir-associated biliary lithiasis in an HIV-infected patientCOURBON, Eve; LAYLAVOIX, François; SOULIE, Cathia et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 1, pp 250-251, issn 0305-7453, 2 p.Article

Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patientsDELAUGERRE, Constance; MATHEZ, Dominique; PEYTAVIN, Gilles et al.AIDS (London). 2007, Vol 21, Num 9, pp 1210-1213, issn 0269-9370, 4 p.Article

Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case reportLIEM BINH LUONG NGUYEN; HARENT, Stanislas; PEYTAVIN, Gilles et al.AIDS (London). 2014, Vol 28, Num 13, pp 1995-1997, issn 0269-9370, 3 p.Article

Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIVDOMINGUEZ, Stephanie; GHOSN, Jade; PEYTAVIN, Gilles et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 6, pp 1449-1452, issn 0305-7453, 4 p.Article

Resistant minority species are rarely observed in patients on darunavir/ritonavir monotherapyLAMBERT-NICLOT, Sidonie; FLANDRE, Philippe; MARCELIN, Anne-Genevieve et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 6, pp 1470-1474, issn 0305-7453, 5 p.Article

Atazanavir in pregnancy: impact on neonatal hyperbilirubinemiaMANDELBROT, Laurent; MAZY, Fabienne; FLOCH-TUDAL, Corinne et al.European journal of obstetrics, gynecology, and reproductive biology. 2011, Vol 157, Num 1, pp 18-21, issn 0301-2115, 4 p.Article

Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients: the HEPADOSE studyDOMINGUEZ, Stephanie; GHOSN, Jade; PEYTAVIN, Gilles et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 11, pp 2445-2449, issn 0305-7453, 5 p.Article

Contribution and limit of the model of perfused cotyledon to the study of placental transfer of drugs. Example of a protease inhibitor of HIV: NelfinavirGAVARD, Laurent; BEGHIN, Delphine; FORESTIER, François et al.European journal of obstetrics, gynecology, and reproductive biology. 2009, Vol 147, Num 2, pp 157-160, issn 0301-2115, 4 p.Article

Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudineGHOSN, Jade; CHAIX, Marie-Laure; PEYTAVIN, Gilles et al.Journal of antimicrobial chemotherapy (Print). 2008, Vol 61, Num 6, pp 1344-1347, issn 0305-7453, 4 p.Article

Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In VitroMALET, Isabelle; DELELIS, Olivier; KATLAMA, Christine et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 4, pp 1351-1358, issn 0066-4804, 8 p.Article

Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapyBOFFITO, Marta; ACOSTA, Edward; REGAZZI, Mario et al.Antiviral therapy (London). 2005, Vol 10, Num 3, pp 375-392, issn 1359-6535, 18 p.Article

Absence of association between MDR1 genetic polymorphisms, indinavir pharmacokinetics and response to highly active antiretroviral therapyVERSTUYFT, Céline; MARCELLIN, Fabienne; MORAND-JOUBERT, Laurence et al.AIDS (London). 2005, Vol 19, Num 18, pp 2127-2131, issn 0269-9370, 5 p.Article

The detection of non-adherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determinationDURAN, Ségolène; PEYTAVIN, Gilles; CARRIERI, Patrizia et al.AIDS (London). 2003, Vol 17, Num 7, pp 1096-1099, issn 0269-9370, 4 p.Article

  • Page / 6